The American Lung Association in Ohio has awarded the "Innovation Award" grant to Dr. Stephen Carpenter from Case Western Reserve University - School of Medicine. This grant will support his research on T-Cell responses to tuberculosis and their potential role in vaccine development.
T-Cells are crucial components of the immune system, responsible for recognizing and attacking foreign particles. Dr. Carpenter's study will focus on CD4 T-Cells, which respond specifically to the bacteria causing tuberculosis. His research aims to advance vaccine development against TB, a disease that, despite being largely eradicated in the United States since 1950, continues to affect 10 million people globally.
Kim Covey, Executive Director at the Lung Association in Ohio, stated: “In 2024, the American Lung Association is celebrating 120 years of funding lifesaving research. Lung Association researchers have achieved major milestones, including helping end the devastation of tuberculosis in this country." She further expressed pride in supporting lung research conducted in Ohio and welcomed Dr. Carpenter as part of their Research Institute team.
The American Lung Association Research Institute announced a $22 million investment over the past year into lung health research. This makes it one of the largest programs nationwide focused on this area. The association funded 139 research grants across various categories related to lung disease.
The association is currently accepting applications for its next cycle of research awards and grants for 2025-2026. Further details can be found at Lung.org/awards or about their current awardees at Lung.org/research-team.
